- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 5th, 2007
Im's research could have applications in nanotechnology and pharmaceuticals.
"The aim of our work is to understand human disease at the molecular level," said Im. "If you look at the drugs that we're using now, about 50 percent of commercial drugs are targeting membrane proteins. As our research progresses, we hope to help make a map to develop the drugs of the future."
A committee of researchers reviews more than 500 nominations each year to determine a final selection of 116 Sloan fellows in seven scientific fields.
|Related News Press|
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
A nano-roundabout for light December 10th, 2016
Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016
Quantum obstacle course changes material from superconductor to insulator December 1st, 2016